PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Research identifies key enzyme target to fight deadly brain cancers

Ohio State scientists discover promising approach to inhibit glioblastoma growth

2025-04-18
(Press-News.org) COLUMBUS, Ohio – Researchers have found that targeting an enzyme called PGM3 can help stop the growth of glioblastoma, the most dangerous type of brain tumor.

This enzyme plays a vital role in the hexosamine synthesis pathway, which is involved in the processes of protein and lipid glycosylation that allow tumors to rapidly grow. Lipid glycosylation is a process where sugar molecules attach to fats (lipids) in the body.

Researchers with The Ohio State University Comprehensive Cancer Center – Arthur G. James and Richard J. Solove Research Institute believe that targeting PGM3 can reduce tumor growth and eliminate glioblastoma cells.

“This research is important because it has found a new target called PGM3. Blocking the PGM3 enzyme can break the connection between sugar and fat creation in cells, which helps stop tumors from growing. By targeting this enzyme, we can develop more effective treatments for glioblastoma, a brain tumor with very few effective treatment options," said study lead author Deliang Guo, PhD, the founding director of the Center for Cancer Metabolism. 

Glioblastoma is a fast-growing brain tumor that develops from glial cells in the brain. An estimated 15,000 people each year are diagnosed with this lethal brain tumor, according to the Glioblastoma Foundation.

The study highlights a promising new approach to fight glioblastoma, giving hope for future advancements in cancer treatment, said Guo, who also is the Urban and Shelly Meyer Professor of Cancer Research with the OSUCCC – James Translational Therapeutics Program and a professor of Department of Radiation Oncology at The Ohio State University College of Medicine.

Study findings are published online in the journal Science Advances.

“Glioblastoma is the most lethal primary brain tumor, with a median survival of only 12-16 months from diagnosis despite extensive treatments,” said Huali Su, PhD, the first author of the paper, and a researcher with the Department of Radiation Oncology and Center for Cancer Metabolism at OSUCCC-James. “New molecular targets for glioblastoma are urgently needed.”

The research team included scientists from France, along with the University of California-Los Angeles, University of California-Irvine and University of Louisville.

This work was supported by grants from the National Institute of Neurological Disorders and Stroke and National Cancer Institute, along with funds from OSUCCC-James, the Urban and Shelly Meyer Foundation.

The authors declare no competing interests.

###

 

 

 

END



ELSE PRESS RELEASES FROM THIS DATE:

New study unveils volcanic history and clues to ancient life on Mars

2025-04-18
In a groundbreaking study co-authored by a Texas A&M University scientist, researchers have revealed new insights into the geological history of Mars' Jezero Crater, the landing site of NASA’s Perseverance rover. Their findings suggest that the crater's floor is composed of a diverse array of iron-rich volcanic rocks, providing a window into the planet’s distant past and the closest chance yet to uncover signs of ancient life. Research scientist Dr. Michael Tice, who studies geobiology and sedimentary geology in the Texas A&M College of Arts and ...

Monell Center study identifies GLP-1 therapies as a possible treatment for rare genetic disorder Bardet-Biedl syndrome

2025-04-18
PHILADELPHIA, PA (April 17, 2025) – A Monell Chemical Senses Center study published this week in the Journal of Clinical Investigation offers renewed hope for individuals living with Bardet-Biedl Syndrome (BBS), a rare genetic disorder characterized by early-onset obesity, compulsive eating, and cognitive impairments. The Monell team and colleagues identified that GLP-1 receptor agonists, a class of drugs currently used to treat type-2 diabetes and obesity, as a promising therapeutic for managing the metabolic complications associated with BBS. They used ...

Scientists probe the mystery of Titan’s missing deltas

2025-04-18
PROVIDENCE, R.I. [Brown University] — For scientists who want to learn about the geological history of a planet, river deltas are a great place to start. Deltas gather sediment from a large area into one place, which can be studied to reveal climate and tectonic histories or signs of past life. That’s why NASA sent its most recent Mars rover to Jezero Crater, home to a prominent and well-preserved delta.  And that’s why planetary scientists are also interested in finding deltas on Saturn’s moon Titan. Titan is the only planetary body ...

Q&A: What makes an ‘accidental dictator’ in the workplace?

2025-04-18
UNIVERSITY PARK, Pa. — The professional world has no shortage of micromanagers — or, as Penn State School of Labor and Employment Relations (LER) faculty members Craig L. Pearce and Hee Man Park like to call them, “accidental dictators.” But leaders don’t have to fall into that trap, according to an article published in the journal Organizational Dynamics co-written by Pearce, Brova Family Endowed Professor of leadership and human resources, and Park, associate professor of human resource management and director of LER’s graduate program. The journal’s readership is largely made up ...

Lehigh University water scientist Arup K. SenGupta honored with ASCE Freese Award and Lecture

2025-04-18
Lehigh University Senior Research Scientist Arup K. SenGupta, a professor emeritus in the Department of Civil and Environmental Engineering, is the 2025 recipient of the Simon W. Freese Environmental Engineering Award and Lecture, presented by the American Society of Civil Engineers (ASCE). SenGupta, an ASCE Fellow, is an internationally recognized water scientist whose research has led to sustainable solutions for removing arsenic, fluoride, and other contaminants from drinking water around the world. His pioneering work in ion exchange science has also advanced technologies for desalination, wastewater reclamation, and carbon ...

Study highlights gaps in firearm suicide prevention among women

2025-04-18
Just under 4 in 10 women who died by firearm suicide had no documented history of mental or physical health problems in a new study, highlighting a need for prevention strategies tailored to at-risk women. The findings come at a time when suicides have been on the rise, alongside a surge in gun ownership — especially among women, said lead author Laura Prater, an assistant professor in The Ohio State University College of Public Health. In the last two decades, firearm deaths in the U.S., including those involving suicide, increased by almost 50%. Women historically made up 10 to 20% of new gun owners, a percentage ...

People with medical debt five times more likely to not receive mental health care treatment

2025-04-18
People with medical debt in 2023 were about five times more likely to forgo mental health care treatment in the following year due to cost, compared to those without medical debt, according to a study led by researchers at the Johns Hopkins Bloomberg School of Public Health. For their study, the researchers analyzed 2023 and 2024 data from a nationwide survey related to mental health. The researchers found that 33.8% of respondents who reported having had medical debt in 2023 also reported forgoing mental health care for cost-related reasons in 2024, compared ...

Hydronidone for the treatment of liver fibrosis associated with chronic hepatitis B

2025-04-18
Background and Aims Liver fibrosis is a key process in the progression of chronic liver diseases. However, there are currently no drugs specifically designed to treat liver fibrosis. Our Phase 2 trial of hydronidone for the treatment of chronic hepatitis B (CHB)-associated liver fibrosis showed that adding hydronidone to entecavir resulted in significant reversal of liver fibrosis. To further evaluate the efficacy of a 270 mg/day dose of hydronidone for treating liver fibrosis associated with CHB, we conducted ...

Rise in claim denial rates for cancer-related advanced genetic testing

2025-04-18
Both the use of next-generation sequencing (NGS) testing for cancer and the rate of claim denials for such testing increased between 2016 and 2021, despite implementation of a recent Medicare national coverage determination that established coverage standards for NGS testing. The analysis by Georgetown University researchers and colleagues, and funded by a grant from the National Cancer Institute at the National Institutes of Health, appears April 18, 2025, in JAMA Network Open. The researchers point to several possible ...

Legalizing youth-friendly cannabis edibles and extracts and adolescent cannabis use

2025-04-18
About The Study: In this serial cross-sectional study of adolescents in grades 7 to 11, legalization of cannabis edibles and extracts was associated with an increase not only in edible cannabis use and cannabis smoking, but also in the overall prevalence of cannabis use and co-use of alcohol and cannabis, highlighting the need for stricter policy measures to curb adolescents’ access to cannabis edibles and extracts and greater awareness among adolescents about harms of cannabis use. Corresponding ...

LAST 30 PRESS RELEASES:

Mapping the Universe, faster and with the same accuracy

Study isolates population aging as primary driver of musculoskeletal disorders

Designing a sulfur vacancy redox disruptor for photothermoelectric and cascade‑catalytic‑driven cuproptosis–ferroptosis–apoptosis therapy

Recent advances in dynamic biomacromolecular modifications and chemical interventions: Perspective from a Chinese chemical biology consortium

CRF and the Jon DeHaan Foundation to launch TCT AI Lab at TCT 2025

Canada’s fastest academic supercomputer is now online at SFU after $80m upgrades

Architecture’s past holds the key to sustainable future

Laser correction for short-sightedness is safe and effective for older teenagers

About one in five people taking Ozempic, Wegovy or Mounjaro say food tastes saltier or sweeter than before

Taking semaglutide turns down food noise, research suggests

Type 2 diabetes may double risk of sepsis, large community-based study suggests

New quantum sensors can withstand extreme pressure

Tirzepatide more cost-effective than semaglutide in patients with knee osteoarthritis and obesity

GLP-1 drugs shown cost-effective for knee osteoarthritis and obesity

Interactive apps, AI chatbots promote playfulness, reduce privacy concerns

How NIL boosts college football’s competitive balance

Moffitt researchers develop machine learning model to predict urgent care visits for lung cancer patients

Construction secrets of honeybees: Study reveals how bees build hives in tricky spots

Wheat disease losses total $2.9 billion across the United States and Canada between 2018 and 2021

New funding fuels development of first potentially regenerative treatment for multiple sclerosis

NJIT student–faculty team wins best presentation award for ant swarm simulation

Ants defend plants from herbivores but can hinder pollination

When the wireless data runs dry

Inquiry into the history of science shows an early “inherence” bias

Picky eaters endure: Ecologists use DNA to explore diet breadth of wild herbivores

Study suggests most Americans would be healthier without daylight saving time

Increasing the level of the protein PI31 demonstrates neuroprotective effects in mice

Multi-energy X-ray curved surface imaging-with multi-layer in-situ grown scintillators

Metasurface enables compact and high-sensitivity atomic magnetometer

PFAS presence confirmed in the blood of children in Gipuzkoa

[Press-News.org] Research identifies key enzyme target to fight deadly brain cancers
Ohio State scientists discover promising approach to inhibit glioblastoma growth